Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
Clinical trial NCT05537038 · COMPLETED
Trial details
- NCT number
- NCT05537038
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2025-06-06
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.